97086 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Protease inhibitors; Endopeptidase (E.C. 3.4.21-99) inhibitors; Serine protease (E.C. 3.4.21) inhibitors Serpins
Sub-classes:COMPOSITION FOR SUBSTITUTING EGG WHITE
#2SERPIN PEPTIDE DERIVATIVES AND METHODS OF USING THE SAME
#3GENETICALLY MODIFIED CELLS FOR ENHANCED IMMUNE EVASION IN ALLOGENEIC CELLULAR THERAPIES
#4GENETICALLY MODIFIED CELLS FOR ENHANCED IMMUNE EVASION IN ALLOGENEIC CELLULAR THERAPIES
#5METHODS OF WOUND HEALING WITH SERP-1 POLYPEPTIDES
#6PARAMYXOVIRUS VIRUS-LIKE PARTICLES AS PROTEIN DELIVERY VEHICLES
#7THERAPEUTIC T CELL PRODUCT
#8SERPIN FUSION POLYPEPTIDES AND METHODS OF USE THEREOF
#9PROTEASE INHIBITORS
#10SYSTEMS AND METHODS FOR PROTEIN EXPRESSION
#11METHODS AND COMPOSITIONS FOR THE TREATMENT OF WOUNDS
#12TREATMENT OF GLAUCOMA
#13PROCESSES FOR MAKING AND USING A MESENCHYMAL STEM CELL DERIVED SECRETOME
#14MODULATING ANTIMICROBIAL PEPTIDE HALF-LIFE
#15SERPIN PEPTIDES AND METHODS OF USING THE SAME
#16TREATMENT OF HEREDITARY ANGIOEDEMA WITH LIVER-SPECIFIC GENE THERAPY VECTORS
#17COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING HEREDITARY ANGIOEDEMA
#18Chimeric inhibitor molecules of complement activation
#19Liver-Specific Nucleic Acid Regulatory Elements and Methods and Use Thereof
#20SERPIN PRODUCTION
#21USING C1 ESTERASE INHIBITOR TO TREAT VIRAL INFECTION-RELATED ACUTE RESPIRATORY DISTRESS
#22GENE-EDITED NATURAL KILLER CELLS
#23Fusion proteins comprising an engineered knottin peptide and uses thereof
#24GENE-EDITED NATURAL KILLER CELLS
#25ADENO-ASSOCIATED VIRUS VECTORS BASED GENE THERAPY FOR HEREDITARY ANGIOEDEMA
#26ENGINEERED CELLS WITH IMPROVED PROTECTION FROM NATURAL KILLER CELL KILLING
#27DETERMINANTS OF CANCER RESPONSE TO IMMUNOTHERAPY
#28Process for Purifying C1-INH
#29SERPIN FUSION POLYPEPTIDES AND METHODS OF USE THEREOF
#30COMPOSITIONS AND METHODS FOR IN UTERO GENE EDITING FOR MONOGENIC LUNG DISEASE
#31Paramyxovirus virus-like particles as protein delivery vehicles
#32OXIDATION-RESISTANT SERPINS
#33Gene-edited natural killer cells
#34Gene-edited natural killer cells
#35PARAMYXOVIRUS VIRUS-LIKE PARTICLES AS PROTEIN DELIVERY VEHICLES
#36NANOCARRIERS HAVING SURFACE CONJUGATED PEPTIDES AND USES THEREOF FOR SUSTAINED LOCAL RELEASE OF DRUGS
#37PROCESS FOR PURIFYING C1-INH
#38Methods of wound healing with Serp-1 polypeptides
#39Fusion proteins comprising an engineered knottin peptide and uses thereof
#40Processes for making and using a mesenchymal stem cell derived secretome
#41Processes for making and using a mesenchymal stem cell derived secretome
#42Methods and compositions for the treatment of wounds
#43Serpin fusion polypeptides and methods of use thereof
#44Bender having a sensor configured to sense a workpiece
#45Chimeric inhibitor molecules of complement activation
#46Serpin fusion polypeptides and methods of use thereof
#47Nanocarriers having surface conjugated peptides and uses thereof for sustained local release of drugs
#48Processes for making and using a mesenchymal stem cell derived secretome
#49Compositions and methods for treating neonatal biliary atresia
#50Serpin fusion polypeptides and methods of use thereof
#51SERPIN FUSION POLYPEPTIDES AND METHODS OF USE THEREOF
#52O-glycan sialylated recombinant glycoproteins
#53Liver-specific nucleic acid regulatory elements and methods and use thereof
#54Follower bar assembly for a bender
#55Paramyxovirus virus-like particles as protein delivery vehicles
#56Determinants of cancer response to immunotherapy
#57ADENO-ASSOCIATED VIRUS MEDIATED DELIVERY OF C1EI AS A THERAPY FOR ANGIOEDEMA
#58Liver-specific nucleic acid regulatory elements and methods and use thereof
#59Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotection
#60Recombinant human C1 esterase inhibitor and uses thereof
#61Serpin reactive center loop peptides and methods of use
#62Modified serpins for the treatment of bleeding disorders
#63Chimeric inhibitor molecules of complement activation
#64Serpin fusion polypeptides and methods of use thereof
#65Compositions and methods for treating neonatal biliary atresia
#66Nanocarriers having surface conjugated peptides and uses thereof for sustained local release of drugs
#67O-glycan sialylated recombinant glycoproteins and cell lines for producing the same
#68CHIMERIC PROTEIN
#69Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotection
#70Functional Peptide Analogs of PEDF
#71Liver-specific nucleic acid regulatory elements and methods and use thereof
#72Paramyxovirus virus-like particles as protein delivery vehicles
#73Chimeric inhibitor molecules of complement activation
#74TAT-CrmA anti-apoptotic fusion proteins
#75Protein recovery
#76Method of inhibiting activity of cell surface fibroblast activation protein alpha
#77Protein biomarkers for immune assessment and prediction of transplant rejection
#78Methods for detecting levels of pigment epithelium-derived factor and antithrombin-III for characterising and/or prognosing prostate cancer
#79Adeno-associated virus mediated delivery of C1E1 as a therapy for angioedema
#80Recombinant fibrinogen high-production line and method for producing same
#81Modified serpins for the treatment of bleeding disorders
#82C1 Inhibitor Fusion Proteins and Uses Thereof
#83COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISEASES OF INFECTIOUS AND NON-INFECTIOUS ORIGIN
#84SERPINS: METHODS OF THERAPEUTIC BETA-CELL REGENERATION AND FUNCTION
#85POLYMERIC CONJUGATES OF C-1 INHIBITORS
#86Serpin fusion polypeptides and methods of use thereof
#87WAP domain fusion polypeptides and methods of use thereof
#88Substrates and inhibitors of antiplasmin cleaving enzyme and fibroblast activation protein and methods of use
#89Serpin fusion polypeptides and methods of use thereof
#90Functional peptide analogs of PEDF
#91Recombinant probiotic bacteria for the prevention and treatment of inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS)
#92Maspin-based treatment of cancer
#93Anti-angiogenic molecules, nanostructures and uses thereof
#94Fusion proteins comprising an engineered knottin peptide and uses thereof
#95Serpin-finger fusion polypeptide
#96Serpin fusion polypeptides and methods of purification thereof
#97Chimeric inhibitor molecules of complement activation
#98WAP domain fusion polypeptides and methods of use thereof
#99Serpin fusion polypeptides and methods of use thereof
#100Maspin-based peptides and methods of use thereof
#101RECOMBINANT PROBIOTIC BACTERIA FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY BOWEL DISEASE (IBD) AND IRRITABLE BOWEL SYNDROME (IBS)
#102POLYPEPTIDES AND USES THEREOF
#103Heparin cofactor II fragments with anti-inflammatory and anti-coagulant activity
#104Anti-apoptotic fusion proteins for reducing myocardial infarction size
#105Liver-specific nucleic acid regulatory elements and methods and use thereof
#106Peptide compositions and methods of use
#107Substrates and inhibitors of antiplasmin cleaving enzyme and fibroblast activation protein and methods of use
#108COMPOSITIONS FOR AND METHODS OF GRAZYME B INHIBITION
#109SERPIN DRUGS FOR TREATMENT OF HIV INFECTION AND METHOD OF USE THEREOF
#110INSECT INHIBITING PLANT SERPIN MUTANTS
#111SERPINE1 POLYMORPHISMS ARE PREDICTIVE OF RESPONSE TO ACTIVATED PROTEIN C ADMINISTRATION AND RISK OF DEATH
#112Insect Inhibition by Plant Serpin
#113METHODS AND COMPOSITIONS FOR THE INHIBITION OF CATHEPSINS
#114RAAV VECTOR-BASED COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF MAMMALIAN DISEASES
#115Glycated peptides and methods of use
#116Method of protein production in yeast
#117Genetically engineered and phenotyped mice and stem cell clones for producing the same
#118Methods and compositions for stabilizing prostate specific antigen
#119Methods of screening for inhibitors of antiplasmin cleaving enzyme
#120Substrates and inhibitors of antiplasmin cleaving enzyme and methods of use
#121Prevention and reduction of blood loss
#122Oligomeric peptides and their use for the treatment of hiv infections
#123Compositions for and methods of granzyme B inhibition
#124Human serpin polypeptides
#125Raav vector-based compositions and methods for the prevention and treatment of mammalian diseases
#126Inhibitor proteins of a protease and use thereof
#127C1-inh as a drug for treating viruses pathogenic to humans
#128Anti-pci neutralizing antibody
#129Chimeric protein
#130Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01
#131Human serine protease and serpin polypeptides
#132Protein modification
#133Mutant proteinase-inhibitors and uses thereof
#134Human serpin polypeptides
#135Methods for treating and preventing sepsis using modified C1 inhibitor or fragments thereof
#136Novel human protease inhibitor and polynucleotides encoding the same
#137Human serpin
#138C1 inhibitor produced in the milk of transgenic mammals
#139Somatic cell line
#140Mammalian telophase oocyte enucleation
#141Brain expressed cap-2 gene and protein associated with bipolar disorder
#142Methods of protein production in yeast
#143Method of decreasing the infectivity of HIV in a biological sample through the administration of S-antithrombin
#144Screening method for compounds that modulate neuronal activity